Symbol | Marktkapitalisierung | Preis | Veränderung % | Volumen | Relatives Volumen | KGV | EPS-Verd. TTM | EPS-Verd. Wachstum TTM YoY | Dividendenrendite % TTM | Analysten-Rating |
---|---|---|---|---|---|---|---|---|---|---|
GRFGRIFOLS S.A. | 5.635 B EUR | 9.328 EUR | +1.46% | 2.089 M | 1.08 | 40.33 | 0.23 EUR | −71.83% | 0.00% | Kauf |
ROVILABORATORIOS FARMACEUTICOS ROVI S.A. | 4.681 B EUR | 87.75 EUR | −0.28% | 120.959 K | 2.88 | 27.25 | 3.22 EUR | −14.01% | 1.19% | Neutral |
ALMALMIRALL S.A. | 2.046 B EUR | 9.775 EUR | +0.05% | 296.225 K | 2.25 | — | −0.18 EUR | +23.28% | 1.52% | Kauf |
FAEFAES FARMA, S.A. | 1.187 B EUR | 3.805 EUR | +0.53% | 730.935 K | 2.93 | 12.86 | 0.30 EUR | +4.19% | 3.93% | Neutral |
PHMPHARMA MAR, S.A. | 684.672 M EUR | 37.40 EUR | +0.43% | 37.941 K | 0.77 | 346.62 | 0.11 EUR | −97.84% | 1.41% | Kauf |
RJFLABORATORIO REIG JOFRE, S.A. | 231.728 M EUR | 2.93 EUR | +2.09% | 36.894 K | 1.75 | 26.14 | 0.11 EUR | +68.57% | 1.11% | — |
PRMPRIM, S.A. | 174.574 M EUR | 10.30 EUR | +0.98% | 1.653 K | 0.72 | — | — | — | 2.88% | Starker Kauf |
ORYORYZON GENOMICS, S.A. | 125.787 M EUR | 1.990 EUR | −1.49% | 239.687 K | 1.39 | — | −0.06 EUR | +24.94% | 0.00% | Starker Kauf |
NTHNATURHOUSE HEALTH, S.A | 98.317 M EUR | 1.640 EUR | −1.50% | 52.939 K | 10.11 | 8.70 | 0.19 EUR | +25.35% | 7.41% | — |
PANGPANGAEA ONCOLOGY S.A. | 56.624 M EUR | 1.86 EUR | 0.00% | 125 | 0.50 | — | — | — | 0.00% | — |
BSTBIOTECHNOLOGY ASSETS, S.A. | 21.796 M EUR | 0.3425 EUR | −1.58% | 53.432 K | 0.82 | — | — | — | 0.00% | — |
VYTVYTRUS BIOTECH, S.A. | 17.219 M EUR | 2.42 EUR | 0.00% | 1.5 K | 0.03 | — | — | — | 0.00% | Starker Kauf |
LABLABIANA HEALTH, S.A. | 16.176 M EUR | 2.24 EUR | 0.00% | 824 | 0.16 | — | — | — | 0.00% | Starker Kauf |